NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-230-2012-0-EP-70 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 EP DIV 22 174 521.9 Pending
NCATS E-128-2019-0-US-07 SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME US National Stage 17/777,654 Pending
NCI E-205-2010-1-US-04 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES US CON 17/746,740 Pending
NCI E-023-2019-0-US-05 INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS US National Stage 17/777,552 Pending
NCI E-040-2012-0-US-65 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/745,067 Pending
NCI E-023-2019-0-CA-03 INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS CA National Stage 3158557 Pending
NCI E-209-2014-0-JP-20 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV 2022-79474 Pending
NCI E-209-2014-0-JP-01 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV
NIAAA E-087-2021-0-PCT-02 A FACILE AND ODOR-FREE APPROACH TO CONVERT UREA/SULFONYL UREA TO CHALCOGENIDE UREA/ SULFONYL UREA PCT PCT PCT/US2022/028942 Expired
NCI E-233-2014-0-JP-11 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2022-077983 Issued
NIAID E-228-2016-1-US-14 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US CON 17/742,201 11793871 Issued PDF
NCI E-096-2021-0-PCT-02 LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS PCT PCT PCT/US2022/028819 Expired
NHLBI E-127-2021-2-PCT-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES PCT PCT COMB PCT/US2022/028510 Expired
NCI E-244-2015-0-EP-13 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use EP DIV 22172554.2 Pending
NEI E-192-2014-1-AU-11 Surgical Tool and Method for Ocular Tissue Transplantation AU DIV 2022203098 Pending
NCI E-192-2020-2-US-02 USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS US National Stage 17/775,262 Pending
NIDA E-053-2016-2-US-07 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF US CON 17/738,301 Pending
NCI E-101-2021-0-PCT-02 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 PCT PCT PCT/US2022/028066 Expired
NIAID E-128-2016-0-EP-07 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONOVIRUSES EP DIV 22171378.7 Pending
NEI E-293-2016-0-JP-08 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2022-75904 Issued
NEI E-293-2016-0-JP-01 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV
NIAID E-089-2022-0-PCT-02 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE PCT PCT PCT/US2022/027136 Expired
NCI E-099-2021-0-PCT-02 LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE PCT PCT PCT/US2022/027082
NCI E-079-2020-2-US-02 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN US National Stage 17/773,494 Pending
NHLBI E-123-2022-0-US-02 SYSTEMS AND METHODS FOR SPIRAL-IN-OUT LOW FIELD MRI SCANS US ORD 17/733,970 Pending
NHLBI E-142-2021-0-US-02 System And Method For Maxwell Compensation For Spiral Turbo-Spin-Echo Imaging US ORD 17/732,155 11860258 Issued PDF
NIDA E-122-2022-0-US-02 Antibodies Against Fentanyl and Fentanyl Analogs US ORD 17/661,160 Pending
NIDDK E-126-2021-0-PCT-02 Purine Nucleosides, Their Intermediates, And Methods Of Preparation Thereof PCT PCT PCT/US2022/071971 Expired
NIAID E-239-2020-0-PCT-02 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE PCT PCT PCT/US2022/026576 Expired
NEI E-227-2018-0-CN-06 Druggable Taraget to Treat Retinal Degeneration CN National Stage 202080075532.5 Pending
NIAID E-221-2022-2-PC-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE PCT PCT PCT/US2022/026409 Expired
NHGRI E-175-2019-0-EP-03 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA EP National Stage 20804709.2 Pending
NIAID E-221-2022-2-CN-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE CN National Stage 202280037491.X Pending
NIA E-062-2021-0-PCT-02 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE PCT PCT PCT/US2022/025764 Expired
NCI E-185-2019-0-US-08 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US National Stage 17/770,940 Pending
NIAID E-202-2018-0-US-03 PST2238 (Rostafuroxin) As An Antiviral Drug Against Respiratory Syncytial Virus (RSV) US DIV 17/725,331 Pending
NIAID E-139-2006-0-US-71 DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US CON 17/724,037 11746335 Issued PDF
NCI E-065-2015-0-US-14 GRIFFITHSIN MUTANTS US CON 17/724,342 Pending
NCI E-191-2019-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION PCT PCT PCT/US2022/025177 Expired
NIAID E-090-2021-0-PC-01 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use PCT PCT PCT/US2023/065775 Pending
NIAID E-216-2014-0-US-17 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US CON 17/721,188 Abandoned
NIBIB E-005-2012-3-CN-13 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS CN DIV 202210413867.4 Pending
NEI E-227-2018-0-ID-08 Druggable Taraget to Treat Retinal Degeneration ID National Stage P-00202204386 Pending
NCI E-174-2018-2-GB-18 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY GB DIV 2205417.5 Issued
NIA E-151-2017-0-US-12 FATTY ACID DERIVATIVES AND THEIR USE US DIV 17/718,965 Pending
NCI E-190-2014-0-AU-46 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2022202408 Pending
NCI E-139-2015-0-US-05 FIXATIVES AND METHODS OF USE US DIV 17/716,606 Pending
NEI E-227-2018-0-IN-09 Druggable Taraget to Treat Retinal Degeneration IN National Stage 202247021119 Pending
NCI E-230-2012-0-HK-68 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 HK CN 42022051280.0 Pending
NIDDK E-138-2017-0-JP-20 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS JP DIV 2022-63285 Pending